HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Norman Roberts lissencephaly syndrome

Also Known As:

Lissencephaly 2; Lissencephaly syndrome, Norman-Roberts type

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Nervous System Diseases: 14178
- Nervous System Malformations: 35
  - Malformations of Cortical Development: 376
    - Group II Malformations of Cortical Development: 62
      - Lissencephaly: 236
        Norman Roberts lissencephaly syndrome: 1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Congenital Abnormalities: 25723
  - Nervous System Malformations: 35
    - Malformations of Cortical Development: 376
      - Group II Malformations of Cortical Development: 62
        Lissencephaly: 236
        Norman Roberts lissencephaly syndrome: 1

Related Diseases

1.	Porencephaly
2.	Classical Lissencephalies and Subcortical Band Heterotopias
3.	Stroke (Strokes)
4.	Thanatophoric Dysplasia (Dwarfism, Thanatophoric)
5.	Microcephaly

Experts

1.	Dewar, K: 1 article (12/2012)
2.	Dunham, C P: 1 article (12/2012)
3.	Hendson, G: 1 article (12/2012)
4.	Money, D M: 1 article (12/2012)
5.	Prayer, D: 1 article (12/2012)
6.	Pugash, D: 1 article (12/2012)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Norman Roberts lissencephaly syndrome:

1.

12/01/2012 - "There were three patterns of abnormal cerebral lamination: (1) no normal laminar pattern before 28 weeks (n=32), in association with severe ventriculomegaly, diffuse ischemia, microcephaly, teratogen exposure or lissencephaly; (2) focal disruption of lamination before 28 weeks (n=24), associated with hemorrhage, porencephaly, stroke, migrational abnormalities, thanatophoric dysplasia, meningomyelocele or encephalocele; (3) increased prominence and echogenicity of the intermediate zone before 28 weeks and/or persistence of a laminar pattern beyond 33 weeks (n=10), associated with Type 1 lissencephaly or CMV infection. "